Date published: 2025-10-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

E130120F12Rik Activators

Zfp953, a zinc finger protein, holds a crucial role as a DNA-binding transcription factor with specificity for RNA polymerase II cis-regulatory region sequences. Its predicted functions include enabling DNA-binding transcription factor activity and participating in the regulation of transcription by RNA polymerase II. Active within the nucleus, Zfp953 plays a pivotal role in orchestrating gene expression, linking its activities to critical cellular processes. The target's involvement in RNA polymerase II-mediated transcription suggests a central role in the modulation of gene regulatory networks.

The activation of Zfp953 involves a complex interplay of chemical modulators influencing diverse cellular pathways. These pathways encompass epigenetic modifications, DNA damage response, nucleotide metabolism, and chromatin remodeling. Chemicals such as retinoic acid, cisplatin, and trichostatin A may directly or indirectly up-regulate Zfp953 by impacting its DNA-binding transcription factor activity and RNA polymerase II-specific functions. The intricate involvement of Zfp953 in these pathways underscores its adaptability and responsiveness to various cellular cues. The activation mechanisms highlight the dynamic interplay of epigenetic and genomic processes, demonstrating the nuanced regulation of Zfp953's engagement in transcriptional control within the nucleus. Further exploration of these pathways promises to unveil additional layers of complexity, providing insights into the molecular orchestration directed by Zfp953 in the intricate landscape of gene regulation.

SEE ALSO...

Items 11 to 11 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$92.00
$209.00
33
(5)

Methotrexate, an antimetabolite, may indirectly activate Zfp953. By interfering with nucleotide synthesis, it could trigger cellular responses that influence the regulation of transcription by RNA polymerase II. This may involve activation of signaling pathways leading to enhanced Zfp953 expression and its subsequent role in the regulation of transcription within RNA polymerase II cis-regulatory regions in the nucleus. Methotrexate's impact on nucleotide metabolism may serve as a signal for the up-regulation of Zfp953 and its involvement in transcriptional control.